Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ArQule and GenQuest cancer collaboration

Sep. 1, 1997

Panretin trial in KS halted early

Aug. 29, 1997

Notice of allowance for LHRH vaccine patent

Aug. 29, 1997

ImmunoGen's apoptosis research receives patent protection

Aug. 28, 1997

Phase II trials of ISIS-3521 begin

Aug. 27, 1997

U.S. patent issued for CEP-2563

Aug. 27, 1997

Antineoplastic peptides from BASF

Aug. 26, 1997

Targeted Genetics receives patent protection for tgDCC-E1A

Aug. 26, 1997

Microtubule inhibitor with low toxicity and unique profile of CaM activity

Aug. 25, 1997

Apoptosis modulators reported in patent literature

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...